Literature DB >> 10534522

Mobilization of lead from bone in end-stage renal failure patients with secondary hyperparathyroidism.

M Kessler1, P Y Durand, T C Huu, M J Royer-Morot, J Chanliau, P Netter, M Duc.   

Abstract

BACKGROUND: It is now recognized that long-term exposure to even low levels of lead may increase bone lead content. Lead can then be released in toxicologically significant amounts during critical states of increased bone turnover.
METHODS: Two patients with end-stage renal failure, one on haemodialysis and the other on continuous ambulatory peritoneal dialysis (CAPD), had been exposed to lead and developed secondary hyperparathyroidism. An edetate calcium disodium (EDTA) test was performed in combination with haemofiltration or CAPD before and after parathyroidectomy.
RESULTS: Before parathyroidectomy, both patients had low delta aminolaevulinic acid dehydrase (ALA-D) and high concentrations of chelated lead. After parathyroidectomy, there was a dramatic decrease in chelated lead and the ALA-D returned to normal.
CONCLUSION: Secondary hyperparathyroidism increases mobilization of bone lead in dialysis patients with an elevated lead burden. This may cause toxic effects.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10534522     DOI: 10.1093/ndt/14.11.2731

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  6 in total

1.  High prevalence of elevated lead levels in pediatric dialysis patients.

Authors:  Guido Filler; Elizabeth Roach; Abeer Yasin; Ajay P Sharma; Peter G Blake; Liju Yang
Journal:  Pediatr Nephrol       Date:  2012-04-17       Impact factor: 3.714

2.  Blood Lead in End-Stage Renal Disease (ESRD) Patients who were on Maintainence Haemodialysis.

Authors:  Subha Palaneeswari M; P M Abraham Sam Rajan; Silambanan Santhi
Journal:  J Clin Diagn Res       Date:  2012-10-14

3.  Positive correlation between environmental PM2.5 and blood lead levels in patients undergoing maintenance hemodialysis.

Authors:  Chao-Yu Chen; Ming-Hui Liu; Ching-Wei Hsu; Cheng-Hao Weng; Tzung-Hai Yen; Wen-Hung Huang
Journal:  Ther Clin Risk Manag       Date:  2017-04-24       Impact factor: 2.423

4.  Environmental lead exposure accelerates progressive diabetic nephropathy in type II diabetic patients.

Authors:  Wen-Hung Huang; Ja-Liang Lin; Dan-Tzu Lin-Tan; Ching-Wei Hsu; Kuan-Hsing Chen; Tzung-Hai Yen
Journal:  Biomed Res Int       Date:  2013-02-28       Impact factor: 3.411

5.  Treatment of lead and arsenic poisoning in anuric patients - a case report and narrative review of the literature.

Authors:  Chun-Yuan Hsiao; Chip Gresham; Mark R Marshall
Journal:  BMC Nephrol       Date:  2019-10-17       Impact factor: 2.388

6.  Blood lead level: an overlooked risk of carpal tunnel syndrome in hemodialysis patients.

Authors:  Wen-Hung Huang; Ching-Chih Hu; Tzung-Hai Yen; Ching-Wei Hsu; Cheng-Hao Weng
Journal:  Ren Fail       Date:  2019-11       Impact factor: 2.606

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.